Phase Ib Trial of Trastuzumab Emtansine In Combination With Lapatinib Plus Abraxane In Metastatic Her 2 Neu Over-Expressed Breast Cancer Patients
Phase of Trial: Phase I
Latest Information Update: 17 Apr 2019
Price : $35 *
At a glance
- Drugs Lapatinib (Primary) ; Paclitaxel (Primary) ; Trastuzumab emtansine (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions
- Acronyms STELA
- 12 Apr 2019 Status changed from active, no longer recruiting to completed.
- 31 Aug 2018 Biomarkers information updated
- 25 Jul 2018 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.